Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walgreens Grows Internationally With Alliance Boots Stake

This article was originally published in The Pink Sheet Daily

Executive Summary

Walgreens is acquiring 45% of the U.K.-based international retailer and wholesaler Alliance Boots, which runs pharmacies in 11 countries, with an option to acquire the entire firm in three years.

You may also be interested in...



European Notebook: EMA Meetings Go (Somewhat) Public; Walgreens’ Global Reach; Scottish Independence?

The European Medicines Agency moves closer to U.S.-style advisory committee meetings in public; two national referendums next month could hit Scotland’s biotech industry and Switzerland’s health insurance sector.

McKesson/Celesio Deal Targets Generics Purchasing Synergies

McKesson believes its acquisition of European drug wholesaler Celesio will result in $275 million to $325 million in synergies four years out, and much of the savings will be achieved through generic drug purchasing.

European Notebook: Renewed Calls For German Pricing Law Changes, Spain Gauges The Value Of Innovation

German health insurers run a cash surplus in the first quarter; Celesio CEO dismissed; Bayer celebrates 150 years; Spain wants to evaluate value for drug pricing; France's drug spend declines in 2012, and more.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS074305

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel